Ledger.Open graph →
SEC Form D · Amendment · filed December 13, 2018

Aura Biosciences, Inc

Offering
$42.5M
Sold
$42.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Alan E. Walts, Ph.D · Cambridge, MADirectorJoel E. Jean-Mairet, Ph.D · Cambridge, MADirectorLewis E. Geffen · Cambridge, MAExecMark E. Chin · Cambridge, MADirectorDale E. Pfost, Ph.D · Cambridge, MADirectorCasper E. Breum · Cambridge, MADirectorArt E. Pappas · Cambridge, MADirectorJulie E. Feder · Cambridge, MAExecElisabet De Los Pinos, Ph.D · Cambridge, MAExec · DirectorDeepak Sindwani · Boston, MAExecHarold D. Keller · Columbus, OHDirectorMichael Hand · PONTE VEDRA BEACH, FLDirectorPeter B. Franz · PONTE VEDRA BEACH, FLDirectorRichard L. Mcquady · Columbus, OHDirectorJohn P. Lee · Columbus, OHDirectorDenise A. Olsen · CHICAGO, ILExec · DirectorDarsh Singh · Austin, TXExecEric M. Siegal · CHICAGO, ILExec · DirectorDennis S. Guest · Columbus, OHDirectorThomas T. Loos · Columbus, OHDirectorDaniel M. Slane · COLUMBUS, OHDirectorSusan E. Weaver · Columbus, OHDirectorMichael A. Bruun · NEW YORK, NYExecJack T. Benson, Do · Columbus, OHDirectorJoseph T. Worischeck, Md · Columbus, OHDirectorNicholas R. Smith · Washington, Washington, D.C.Exec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗